Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma

Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma

PurposeThe purpose of this study was to retrospectively analyze the safety and clinical efficacy of anlotinib combined with dose-dense temozolomide (TMZ) as the first-line therapy in the treatment of recurrent glioblastoma (rGBM).Patients and MethodsWe collected the clinical data of 20 patients with...

Full description

Bibliographic Details
Main Authors: Lei She, Lin Su, Liangfang Shen, Chao Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
recurrent glioblastoma
anlotinib
dose-dense temozolomide
efficacy
survival
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.687564/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.687564/full

Similar Items